Detection and identification of toxic agents are important for medical diagnostics, food/water safety testing, and biological warfare defense. The prevalent detection methods are polymerase chain reaction (PCR) and immunoassay based on antigen-antibody interactions. The PCR-based genetic analysis offers high sensitivity and unambiguous identification of microorganisms such as bacteria, from which nucleic acids can be extracted for amplification. The immunoassay-based approaches are more suitable for toxin detection, since most toxins available in nature are proteins. An individual immunoassay detects only one analyte per test. However, the one-analyte-per-test immunoassay is inefficient for the requirement to detect a spectrum of analytes. For instance, a variety of bioterrorism toxins, including botulinum toxin, ricin, cholera toxin, and Staphylococcus aureus enterotoxin B, should be monitored in foods and other samples. Therefore, an approach to detect them rapidly and simultaneously will be an ideal platform for better efficiency and lower cost.
One of the critical components to realize the controlled manipulation of fluids in microsystems is microvalves. An array of microvalves is required for large-scale integration of microfluidic components; they are needed for containing fluids, directing flows, and isolating one region from others in the microfluidic array. However, creation of reliable valves in a microfluidic device is quite challenging due to the scaling laws.1,2. Anderson et al.1 used diaphragm and hydrophobic vents to isolate DNA amplification chambers, which were also employed by Legally et al.2 Others exploited the phase change of a material; examples include freezing and melting of a fluid3 or paraffin4-6. Quake's group invented elastic membrane valves in multilayer structures while actuation of valves was achieved by vacuum and pressure7,8 Localized gel valves have also been explored for isolation of a DNA amplification region from an electrophoresis channel9 and for flow control inside microfluidic channels.10 In addition, many valves exist in the literature that were fabricated using traditional silicon-based MEMS (microelectromechanical systems) techniques, which are often not compatible to the manufacturing processes of commercial microfluidic devices that are based on glass or plastics. For those valves made in polydimethylsiloxane-based devices, the overall device fabrication could be difficult in industrial settings. For those valves using vacuum and pressure as the actuation mechanism, the operation could be very cumbersome to users and the actuation mechanism is difficult to be integrated in a device.
Certain embodiments of the subject invention are based on the inventors discovery and development of microfluidic valves that are manufacturable and compatible with a printed circuit board (PCB) and packaging technology currently used in the semiconductor and computer industry. The valves are actuated by microfabricated thermal resistors and a temperature-sensitive reagent, thus being reliable, easy to operate, and compatible to various fluidic components. The thermal-sensitive reagent includes fluids, gels, solids, and other thermal-response materials.
In addition to thermal actuation, valves can be actuated piezoelectric motion, electroactive polymers, electrostatic attraction, and other current-driven and voltage-driven mechanisms.
Compared to microplates or conventional protein arrays, microfluidic array devices and methods taught herein offer many advantages, including, but not limited to, short analysis time due to rapid interactions in the confined areas, reduced false positives from reagent contamination because of the physical separation by valves and channels, and minimum cost without the requirement for expensive equipment to pattern proteins. In addition, miniaturization provides other advantages including minimization of required sample and reagents.
Although this invention is illustrated by detecting multiple toxic agents, the method can easily be used by those who are skilled in the art for detection of other analytes. The analytes include proteins, antigens, ligands, and other analytes recognized by immunological interactions; deoxyribonucleic acids (DNA), ribonucleic acids (RNA), and the like recognized by complimentary nucleic acids; the compounds recognized by aptamers, peptides, carbohydrates and glycosphingolipids; and biological cells, particles, and the materials recognized by these specific interactions.
Some of the aspects of the subject invention involve:
Large-scale integration of an array of microfluidic valves with other components. These valves are fabricated using micromachining and molding, and actuated by microfabricated thermal resistors, electroelastic expansion, or other electronically actuated motion. Other integrated components may include thermal-sensitive materials, electroelastic materials, and temperature sensors.
Custom-micromachined PCB compatible to an array of microfluidic valves and temperature sensors. The PCB is hybrid-packaged with the device and an electronic interface for rapid analyte detection. In one embodiment, the heater and temperature sensor may be integrated in the PCB layer which is laminated to the microfluidic array. The PCB also contains interface electronics that deliver the actuation signal to the microvalve actuator and measure the sensing signal such as temperature in order to realize closed-loop and open-loop modes of operation.
Implementation of microfluidics-enabled, antibody microarray for detection of analytes. The microarray is in the format of a sandwich assay, each of which comprises a capture antibody, analyte, and secondary detection antibody conjugated with a fluorescent dye or an enzyme or another moiety to facilitate detection.
In certain embodiments, the subject invention provides a high-throughput approach to detect a spectrum of analytes such as toxins. With the potential use of biological weapons against American citizens and assets, the ability to simultaneously screen a large number of samples and detect a wide range of agents has become essential. Secondly, embodiments of the invention offer a unique method for large-scale integration of microfluidic components. The method offers a manufacturable process that allows mass production and leads to low-cost, disposable devices.
Microfluidics. Microfluidics technology has been used to construct miniaturized analytical instruments called “Lab-on-a-chip” devices. In analogy to shrinking a computer in the size of a room in 1950's to a laptop today, instruments for chemical and biological analyses may be miniaturized using modern microfabrication technology. The principles of microfabrication and microfluidics, as well as their current and potential applications, have been reviewed in the literature.11,12 Common analytical assays, including PCR, protein analysis, DNA separations, and cell manipulations have been reduced in the size and fabricated in a centimeter-scale chip. The size reduction of an analytical instrument has many advantages including high speed of analysis, minimization of required sample and reagents, and ability to operate in a high-throughput format.
We have previously reported fabricating a variety of microfluidic devices for applications including synthesis of a library of compounds for combinatorial chemistry,13 DNA hybridization for studying gene expression,14 DNA sequencing,15,16 protein separation,17-19 and bacterial detection.9
Printed circuit board and large-scale integration. Case studies of successful micromachined sensors indicate the importance of concurrent design of the sensor and the package.20 Unlike conventional integrated circuits where nearly all packages are readily available and standardized for routing electrical signals, packages for sensors often require custom designs for the specific analyte and operation conditions. To address this, the prevalent approach is to partition the sensor into modules.20 The modular approach results in hybrid sensor systems where each partition is fabricated using the optimal fabrication techniques for the specific module. For example, the microfluidics module is fabricated using chemically resistant plastics while the electronics module is designed using commercially available integrated circuit components. This results in greater flexibility, lower cost, and higher overall performance than integrating all functionality in a single monolithic fabrication process. Further integration is possible using the printed circuit board (PCB) approach, as it has been employed for hybrid electronic systems to integrate multiple electronic functions. The same PCB approach may be used for hybrid sensor arrays by connecting multiple sensors with electronics (for example, pre-amplifier and analog-to-digital conversion). We have previously demonstrated a sixteen micromachined acoustic transducer array21 using micromachined piezoresistive microphones mounted on a custom PCB. Furthermore, the same PCB may be used as the capping layer for the microfluidic assembly, simultaneously delivering the control signals and recording the sensed signals while also sealing the cavity containing the thermoelastic material.
Toxin detection. The potential use of biological weapons against American citizens and assets is one of the most disturbing threats facing the United States today. For instance, Ricin, a Category B agent defined by the Centers for Disease Control and Prevention (CDC),22 was the toxin sent in a letter to the US Congress in February 2004. Thus a compelling need exists to develop novel techniques for rapid and accurate detection of biological toxins.
One embodiment relates to an array of microfluidic valves and other components to meet the requirement of an antibody array for analyte detection. The microfluidic valves in this invention will enable simultaneous detection of multiple analytes in a sample. The concept is illustrated in a 3×3 array in
After washing all channels, a sample is pumped into all of three vertical channels. At the channel intersections, microfluidic valves (valve-V) indicated by vertical bars will be closed, so that the solution will not flow into horizontal channels. The nine analytes of interest should be captured in the corresponding intersections. For instance, intersections A-1, A-2, and A-3 capture only antigen-1, -2 and -3 if they are present. After washing these channels, three secondary antibodies (2nd Ab-1, 2nd Ab-4, and 2nd Ab-7) specific to antigen-1, -4, and -7 are introduced in vertical channel 1. Similarly, three different antibodies (2nd Ab-2, 2nd Ab-5, and 2nd Ab-8) specific to antigen-2, -5, and -8 are introduced in vertical channel 2. And three other antibodies (2nd Ab-3, 2nd Ab-6, and 2nd Ab-9) specific to antigen-3, -6, and -9 are introduced in vertical channel 3. After appropriate detection reagents are applied, a signal at each location tells specifically the corresponding antigen present in the sample. For example, a signal in the intersection B-1 indicate the presence of antigen-4 in the sample, since the 1St Ab-4 is contained in the horizontal channel 2 and the 2nd Ab-4 is in the vertical channel 1. Other intersections have not been exposed to both 1St Ab-4 and 2nd Ab-4, thus any signal at other intersections has nothing to do with antigen-4.
The operation of microfluidic valves is illustrated in
An alternative valve actuation is illustrated in
Device Fabrication. The materials used for making microfluidic devices include silicon, glass, and plastics, as reviewed.24 We will choose plastics for this invention because of the following reasons. First, a wide range of plastics are available to be selected for a biological assay of interest. The compatibility between plastics and chemical/biological reagents is evident from the fact that many labwares such as microcentrifuge tubes and microplates are made of plastics. Plastic parts made by techniques such as injection molding or embossing can be quite inexpensive: the manufacturing cost of an injection-molded compact disc (CD), a two-layer structure containing micron-scale features, is presently less than 40¢.16 Therefore, plastic microfluidic devices can be made so cheap that they can be disposable after a single use. This could have tremendous impact in applications where cross-contamination of sequential samples is of concern. In alternative embodiments, devices will be fabricated following methods described previously,25 though modification and optimization are carried out to meet the requirements.
In one embodiment, each module is fabricated using the appropriate technology for the required performance at low cost. Specifically, the microfluidics-based detection system are partitioned into microfluidics module, interconnects to microvalve heaters, and electronic addressing and control. The microfluidic channels and microvalves are fabricated as discussed above. The heaters, interconnects, and other components are micromachined directly on the plastic substrate using patterned thin film metal or using thin film deposited on a thin silicon nitride membrane over a cavity for thermal isolation employing a technique previously used for a thermal shear sensors.26 The film could be platinum, gold, chromium, titanium, graphite, and other conducting materials. The heaters can also be fabricating using screen-printing, air-brushing, and other commercial techniques. The electronic addressing and control will be implemented by using a microcontroller mounted on a custom PCB, which also serves as the platform for the overall hybrid system. This modular approach is expected to realize a manufacturable process, and leading to simultaneous high-throughput detection of analytes.
Using four toxins, namely ricin (RN), cholera toxin (CT), Staphylococcus enterotocin B (SEB), and exotoxin A from Pseudomonas aeruginosa (EA), detection conditions are tested using a microfluidic-enabled antibody microarray system.
In the format shown in
For a given toxin, both capture and detection Abs can be prepared from the same polyclonal Ab, or use two monoclonal Abs that recognize two separate epitopes of the toxin. Adjustments can be made in the concentrations of capture and detection antibodies to achieve maximum detection sensitivity without compromising detection specificity. Flow rate of the reagents can also be adjusted to allow maximum Ab-Ag binding. Finally, composition of the washing solution as well as washing time can be optimized to minimize the background signal.
Other embodiments pertain to (i) devices with greater array density; (ii) detection of a comprehensive panel of toxins; (iii) multiple toxin detection from a mixture; (iv) detection of the toxins in various food and environmental samples, such as ground beef, vegetables, milk, juices and waters; and (v) detection of viruses and bacteria. These are all enabled and included as additional embodiments.
While the principles of the invention have been made clear in illustrative embodiments, there will be immediately apparent to those skilled in the art, in view of the teachings herein, many modifications of structure, arrangement, proportions, the elements, materials, and components used in the practice of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from those principles. The appended claims are intended to cover and embrace any and all such modifications, with the limits only of the true purview, spirit and scope of the invention.
The references referred to herein are incorporated herein in their entirety to the extent they are not inconsistent with the teachings herein.
This application claims priority to U.S. Ser. No. 60/908,444 filed Mar. 28, 2007, which is incorporated herein in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US08/58392 | 3/27/2008 | WO | 00 | 8/25/2009 |